Narcotics analgesics Flashcards

1
Q

Three major opioid receptor types that are potential targets for narcotic analgesics

A
  1. µ (Mu)
  2. δ (Delta)
  3. k (Kappa)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What type of receptors are opioid receptors?

A

G-protein coupled receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Sites of opioid receptors regulating pain

A
  1. Peripheral nociceptive terminals (peripheral analgesia)
  2. Spine (spinal analgesia)
  3. Brain (Supraspinal analgesia)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Generally, how do opioid analgesics reduce pain?

A
  1. Inhibit propagation of pain signals
  2. Alter emotional perception of pain
  3. (possibly) elevate pain treshold
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

The opioid receptor most involved in pain mediation

A

µ receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

The opioid receptor that is most associated with Dysphoria

A

k receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

List the dose dependence effects of narcotic analgesics as dose increases, from therapeutic to toxic.

A
  • –Therapeutic—
    1. Peripheral Analgesia (Nociceptive terminals)
    2. Spinal Analgesia (Spine)
    3. Supraspinal Analgesia, (Brainstem)
    4. Sedation (Brainstem)
    5. Euphoria (Emotional Brain)
    6. Cough suppression (Brainstem, Resp Nuclei)
  • –Toxic—
    1. Pupil constriction (Oculomotor)
    2. Constipation, Reduced gut motility
    3. Dysphoria (Emotional Brain)
    4. Severe Sedation (Brainstem)
    5. Respiratory depression (Respiratory Nuclei)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are some dosing considerations for:

  1. Elderly
  2. Type of pain
  3. Chronic pain
A
  1. Elderly: require lower dose to achieve effective pain relief than younger patients
  2. Type of pain: Neuropathic pain rq higher dose than nociceptive
  3. Chronic pain: Lower doses with continuous maintenance rather than administration in response to pain recurrence
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

General rule for dosing opioids

A

Start low, titrate carefully until sufficient analgesia is obtained, or until persistent unacceptable SE requires therapy re-evaluation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Characteristics of opioids in some patients with chronic pain

A

Opioids do not exert appreciable analgesic effect until threshold dose achieved

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What does failure of partial analgesia with incremental in opioid-naive patient indicate?

A

Pain syndrome is unresponsive to opioid therapy. Other medications or procedures may be required, and opioids should not be used

OR

higher doses of opioids are rqeuired

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

List the clinical uses of opioid agonists, and name some drugs associated with each usage

A
  1. Analgesia: Codeine, morphine, pethidine
  2. Anaesthetic adjuvant: Fentanyl
  3. Cough suppressant/antitussive: Codeine
  4. Anti-diarrhoeal: Diphenoxylate
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Name some strong Opioid Agonists

A
  1. Morphine
  2. Fentanyl
  3. Methadone
  4. Pethidine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Describe the properties of Morphine, methadone and Fentanyl such as:

  • Opioid receptor binding
  • Analgesia efficacy
  • Concerns
A
  1. Strong µ agonist. Weaker agonist of other opioid receptors
  2. High Maximum analgesic efficacy
  3. Concern: High liability for addiction or abuse
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Compare the duration of action between Methdaone and Fentanyl

A

Methadone is long-acting (half life > 24h) while Fentanyl is short-acting and used as an anaesthetic adjuvant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Which opioid receptor does pethidine bind strongest to?

A

µ

17
Q

Compare the duration of action between Morphine and Pethidine. What is the usage of pethidine

A

Pethidine has shorter Duration of Action than Morphine. Used in labour and delivery

18
Q

Possible SE of Pethidine at high doses, and what is it caused by?

A

SE: Hallucination, Convulsant

Cause: Pethidine is N-demethylated in the liver to norpethidine, which has these effects

19
Q

Unlike other opioid agonists, what is the SE that may be unique to pethidine?

A

Restlessness (rather than sedation)

20
Q

Other SE of Pethidine?

A

Antimuscarinic side effets: Dry mouth, blur vision

  • No miosis, less spasm of smooth muscle
21
Q

Name some moderate opioid agonists

A
  1. Codeine/Dihydrocodeine

2. Tramadol

22
Q

Why does Codeine/dihydrocodeine show various effectiveness between individuals?

A
  • 10% population lack demethylating enzyme

- Cannot convert codeine/dihydrocodeine to higher efficacy morphine/dihydromorphine

23
Q

Describe the binding of codeine/dihydrocodeine to opioid receptors

A
  • Weak µ and δ agonist

- Probably not a k agonist

24
Q

Describe the binding of Tramadol to opioid receptors

A

Weak µ agonist

25
Q

When Ondansetron, a 5-HT3 antagonist, is taken with tramadol, the effect of tramadol is reduced. What does this show about tramadol?

A

Tramadol may be a weak agonist of 5-HT3, and hence a weak inhibitor of 5-HT and NE re-uptake

26
Q

Describe the mechanism of opioid overdose that leads to the fatal AE of Respiratory Depression

A
  • Actions in Nucleus Tractus Solitarius and Nucleus Ambiguus
  • Causes reduction to responses to CO2 and H+
  • Hence suppresses voluntary breathing
27
Q

Risk factors leading to Respiratory Depression in patients taking Opioid agonists

A
  1. Overdose
  2. Respiratory disease
  3. Hepatic dysfunction (hence increased opioids elvel)
  4. Combination with other CNS depressants (e.g. BZD)
  5. Young Children (hence avoided in infants)
28
Q

Generally, what are the common AE of opioid agonists, and the possible mechanism that causes the AE?

A
  1. Nausea/vomiting due to chemoreceptor trigger zone in postrema of medulla (reduces with repeated or chronic use)
  2. Drowsiness
  3. Constipation due to reduced GI motility (especially with chronic use)
29
Q

Generally, what are the other AE of opioid agonists, and the possible mechanism that causes the AE?

A
  1. Miosis due to actions in oculomotor nucleus
  2. Urinary retention due to increased bladder sphincter tone (esp. in BPH)
  3. Postural Hypotension and Bradycardia due to actions in cardioregulatory nuclei in medulla)
  4. Immunosuppressant when used long-term, due to CNS effects on immune system
  5. Morphine: Trigger histamine release from mast cells causing allergy reactions
30
Q

Can morphine be used in asthmatics?

A

Yes (or not at all), but with caution as morphine trigger hsitamine release from mast cells that can cause allergic reactions

31
Q

Allergic SEs of Morphine

A
  1. Urticaria and itching
  2. Bronchoconstriction
  3. Hypotension due to Vasodilation
32
Q

One possible diagnostic feature of opioid overdose

A

Pinpoint pupil (constricted pupil) due to actions in oculomotor nucleus

33
Q

In a patient with opioid overdose, what is a possible diagnostic feature?

A

Miosis (pinpoint pupils) , but mydriasis if patient alr has hypoxia

34
Q

Define:

  1. Tolerance
  2. Addiction
  3. Physical Dependence

Of drugs

A
  1. Tolerance: where a certain dose of drug becomes less effective after prolonged use, and dose escalation is required to achieve the same effect
  2. Addiction: Psychological craving for a drug, or compulsive and loss of control over use
  3. Physical Dependence: Stopping drug leads to physical withdrawal sx
35
Q

Why is Heroin no longer used?

A

High risk of addiction and tolerance leads to risk of overdose

36
Q

Name some examples of opioid withdrawal sx

A
  1. Anxiety
  2. Irritability
  3. Chills
  4. Hot flushes
  5. Joint pain
  6. Lacrimation
  7. Rhinorrhea
  8. Nausea
  9. Vomiting
  10. Abdominal cramps
  11. Diarrhea
37
Q

Drugs to treat Opioid overdose, and their Mechanism of Action

A

Drug: Naloxone, Naltrexone, Nalmefene

MoA: Strong µ antagonism, some δ and k antagonism, displaces opioid agonists from receptors

38
Q

Route of Administration and Duration of Action of the Opioid Antagonists

A
  1. Naloxone: Short-acting, usually IV
  2. Naltrexone: Long-acting, PO
  3. Nalmefene: Long-acting, IV
39
Q

Can Opioid Antagonists be used in patients with opiate dependency?

A

Yes, but with extreme caution: may precipitate fatal withdrawal syndrome when used